Abstract:Bordetella avium causes a highly infectious upper respiratory tract disease in turkeys and other poultry with high economic losses. Considering the antimicrobial resistance crisis, bacteriophages (phages) may be an alternative approach for treating bacterial infections such as bordetellosis. Here, we describe seven B. avium phages, isolated from drinking water and feces from chicken and turkey farms. They showed strong bacteriolytic activity with a broad host range and used lipopolysaccharides (LPS) as a host receptor for their adsorption. All phages are myoviruses based on their structure observed by transmission electron microscopy. Genome sequence analyses revealed genome assembly sizes ranging from 39,087 to 43,144bp. Their permutated genomes were organized colinearly, with a conserved module order, and were packed according to a predicted headful packing strategy. Notably, they contained genes encoding putative markers of lysogeny, indicative of temperate phages, despite their lytic phenotype. Further investigation revealed that the phages could indeed undergo a lysogenic life cycle with varying frequency. However, the lysogenic bacteria were still susceptible to superinfection with the same phages. This lack of stable superinfection immunity after lysogenization appears to be a characteristic feature of B. avium phages, which is favorable in terms of a potential therapeutic use of phages for the treatment of avian bordetellosis. IMPORTANCE To maintain the effectiveness of antibiotics over the long term, alternatives to treat infectious diseases are urgently needed. Therefore, phages have recently come back into focus as they can specifically infect and lyse bacteria and are naturally occurring. However, there is little information on phages that can infect pathogenic bacteria from animals, such as the causative agent of bordetellosis of poultry, B. avium. Therefore, in this study, B. avium phages were isolated and comprehensively characterized, including whole-genome analysis. Although phenotypically the phages were thought to undergo a lytic cycle, we demonstrated that they undergo a lysogenic phase, but that infection does not confer stable host superinfection immunity. These findings provide important information that could be relevant for potential biocontrol of avian bordetellosis by using phage therapy.

Monoclonal antibodies directed against the outer membrane protein of Bordetella avium

Development of a Harmonized Method for Antimicrobial Susceptibility Testing of Bordetella Avium Using Broth Microdilution and Detection of Resistance Genes.

Lactococcus Lactisanchoring Avian Infectious Bronchitis Virus Multi-Epitope Peptide EpiC Induced Specific Immune Responses in Chickens

Characterization of Temperate LPS-Binding <i>Bordetella avium</i> Phages That Lack Superinfection Immunity

Component Identification and Functional Analysis of Outer Membrane Vesicles Released by Avibacterium paragallinarum

Preparation and Identification of Monoclonal Antibodies Against M Protein of Avian Infectious Bronchitis Virus

Monoclonal-Antibodies Against Mycobacterium-Avium Intracellulare

Development of a Blocking ELISA for Detection of Mycoplasma Hyopneumoniae Infection Based on a Monoclonal Antibody Against Protein P65.

Preparation and Identification of Monoclonal Antibody Against Cytolysin of Vibrio Vulnificus

[Preparation and primary analysis of monoclonal antibodies against VP5 protein of chicken infectious bursal disease virus]

Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles

Species-Specific Monoclonal Antibodies to Escherichia coli-Expressed p36 Cytosolic Protein ofMycoplasma hyopneumoniae

Preparation and identification of monoclonal antibodies against locale isolated strain of duck hepatitis virus

Expression and characterization of recombinant antibodies against H7 subtype avian influenza virus and their diagnostic potential

Preparation of Monoclonal Antibodies Specific to Type 1 Pili of Avian Escherichia coli and Their Detection to Isolation Strains

Development of High-Production Bacterial Biomimetic Vesicles for Inducing Mucosal Immunity Against Avian Pathogenic Escherichia coli

Enzyme linked aptamer assay: based on a competition format for sensitive detection of antibodies to Mycoplasma bovis in serum.

Preparation of a new monoclonal antibody against subgroup A of avian leukosis virus and identifying its antigenic epitope

Development and characterization of a novel specific monoclonal antibody against mink enteritis virus and its antigen epitope analysis

Production And Characterization Of Monoclonal Antibodies To (Poly100)S1 Protein Of Avian Infectious Bronchitis Virus

A Novel Approach to Development of Monoclonal Antibodies Using Native Antigen for Immunization and Recombinant Antigen for Screening.